Jefferies analyst Jeffrey Holford said the new Treasury action looks like more than just a wrinkle for the Pfizer (NYSE ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE